Business Context and Reporting Period
This Form 8-K Current Report was filed by Nanophase Technologies Corporation (now Solesence, Inc.) on March 12, 2025, reporting events occurring on March 10, 2025. The filing documents a corporate name change and rebranding initiative.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name Change: The Company filed a Certificate of Amendment with the Delaware Secretary of State to change its name from "Nanophase Technologies Corporation" to "Solesence, Inc."
- Effective Date: The name change became effective immediately upon filing on March 10, 2025.
- Strategic Rationale: The change is part of a rebranding effort to highlight the success of the Company's beauty science platform and signal a new focus on innovation, self-expression, and inclusivity in skin health.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, quantitative outlook, or new risk factors. Management commentary is limited to the strategic intent behind the rebranding. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the legal effectiveness of the name change with the Delaware Secretary of State.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for any other amended provisions.
- Confirm the ticker symbol update on relevant stock exchanges following the name change.
- Assess the impact of the rebranding on the Company's existing contracts and intellectual property portfolio.